Creating new antimicrobial drugs will require governments working with industry

  09 April 2019

The pharmaceutical industry has demonstrated its willingness to take on the risk and uncertainty that come with trying to develop medicines that address unmet needs. When it comes to antimicrobial drugs, the hurdle is not that the risks are too high, it is that the rewards are too low. The big question is this: What is society as whole ready to invest to avoid a post-antibiotic era?

Further reading: STAT News
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed